As an expert in yeast fermentation and production since 1923, Lallemand presents a wide range of innovative probiotic yeast solutions. Rediscover S.…
Lallemand Health Solutions launches the brand CEREBIOME® (previously known as Probio’Stick®), a new name for an existing formula combining: Lactobacillus helveticus Rosell®-52…
Lallemand Health Solutions’ three probiotic strains L. helveticus Rosell®-52 (R0052), B. infantis Rosell®-33 (R0033) and B. bifidum Rosell®-71 (R0071), have now completed…
The Lallemand group, in partnership with Biotechnologies Ulysse and Bio-K Plus, all Canadian companies, are joining forces to develop a vaccine against…
The Lallemand group is donating 3,200 surgical and N95 masks to local health authorities in the Montreal (Canada) and Cantal (France) regions,…
With the rapidly evolving COVID-19 pandemic, Lallemand Health Solutions (LHS) further deployed additional measures to its initial contingency plan, to ensure employees…
One of Lallemand Health Solution’s documented strains, Bifidobacterium lactis Lafti® B94 has recently received a No Questions Letter (NQL) regarding the Generally…
Dr. Thomas Tompkins, Research Director at the Rosell Institute for Microbiome and Probiotics, by Lallemand will present the “Impact of a psychobiotic…
As communicated by New Hope Network, Natural Products Expo West 2020 has been officially postponed https://www.expowest.com/en/venue-travel/expo-west-2020-postponement.html Lallemand Health Solutions (LHS) will attend…
Medibiolab, located in Seoul, South Korea, in partnership with Lallemand Health Solutions, are launching a unique formulation of probiotics for the brain-gut…